Tuberculosis among HIV-infected population: incidence and risk factors in rural Tanzania

Afr Health Sci. 2017 Mar;17(1):208-215. doi: 10.4314/ahs.v17i1.26.

Abstract

Background: The incidence of tuberculosis among HIV-infected populations with high CD4 count in high burden countries has not been well studied.

Objective: To assess the TB incidence in HIV-infected adults and its associated risk factors.

Method: A cohort study with retrospective review of medical records and prospective follow-up of HIV-infected adult participants attending CTC who were 18-55 years old, had CD4 count more than 250 cells/mm3 in the period of 2008-2010 and were not on ART at enrolment. Cox proportional hazard regression was used to explore the predictors of incident TB.

Results: Overall 777 (24%) of 3,279 CTC enrolled HIV-infected adults fulfilled the inclusion criteria of the study. The incidence of TB in the study population ranged from 0.8/100 per person years (PY) at risk (95% CI 0.5-1.3) in the main analysis to 1.7/100 PY at risk (95% CI 1.0-2.6) in sensitivity analyses. Only prior history of TB disease was found to have a significant association with an increased risk of TB, hazard ratio 5.7 (95% CI 2.0-16.4, p value 0.001).

Conclusion: Tuberculosis incidence among HIV-infected adults with medium/high CD4 count in Bagamoyo is lower than in other high TB burden countries. Previously TB treated patients have a much higher risk of getting TB again than those who never had TB before.

Keywords: CD4 cell count; Care and Treatment Center; HIV; Tuberculosis.

MeSH terms

  • Adolescent
  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active*
  • CD4 Lymphocyte Count
  • Coinfection
  • HIV Infections / complications*
  • HIV Infections / drug therapy*
  • HIV Infections / epidemiology
  • Hospitals, District
  • Humans
  • Incidence
  • Middle Aged
  • Proportional Hazards Models
  • Risk Factors
  • Rural Population
  • Tanzania / epidemiology
  • Tuberculosis / epidemiology*
  • Young Adult

Substances

  • Anti-HIV Agents